Advertisement

Topics

Medisse BV Company Profile

17:22 EST 11th December 2018 | BioPortfolio

Medisse BV is a leading innovator and developer of synthetic resorbable soft tissue implants. The Company’s first product, FlexiSurge Adhesion Barrier, is currently tested in a clinical study to obtain the clinical data needed for CE marking early in 2015. Medisse is also developing anti-adhesive technologies for use on other implantable medical devices like eg. hernia meshes. Medisse products are currently indicated for investigational use only and have not yet been approved for medical use in any market.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Medisse

Established in 2006, Medisse develops flexible, resorbable implants for soft tissue applications. The Company’s unique FlexiSurge™ technology allows implants to maintain...

Medisse BV

Medisse BV is a leading innovator and developer of synthetic resorbable soft tissue implants. The Company’s first product, FlexiSurge Adhesion Barrier, is currently tested...

More Information about "Medisse BV" on BioPortfolio

We have published hundreds of Medisse BV news stories on BioPortfolio along with dozens of Medisse BV Clinical Trials and PubMed Articles about Medisse BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medisse BV Companies in our database. You can also find out about relevant Medisse BV Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record